Silod, Kienzces Paul E.

HRN: 17-25-56  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/24/2022
CEFUROXIME 1.5GM (VIAL)
09/24/2022
09/30/2022
IV
1.5gm
Q8
T/C Acute Appendicitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: